| # | Title | Journal | Year | Citations |
|---|
|
| 1 | Multiplex PCR for detection of acquired carbapenemase genes | Diagnostic Microbiology and Infectious Disease | 2011 | 1,524 |
| 2 | PCR diagnosis and characterization of Leishmania in local and imported clinical samples | Diagnostic Microbiology and Infectious Disease | 2003 | 715 |
| 3 | Interrelationship between pharmacokinetics and pharmacodynamics in determining dosage regimens for broad-spectrum cephalosporins | Diagnostic Microbiology and Infectious Disease | 1995 | 613 |
| 4 | Determining the value of antimicrobial surveillance programs | Diagnostic Microbiology and Infectious Disease | 2001 | 577 |
| 5 | Detection of pathogenic Leptospira spp. through TaqMan polymerase chain reaction targeting the LipL32 gene | Diagnostic Microbiology and Infectious Disease | 2009 | 450 |
| 6 | Comparison of antimicrobial resistance phenotypes and resistance genes in Enterococcus faecalis and Enterococcus faecium from humans in the community, broilers, and pigs in Denmark | Diagnostic Microbiology and Infectious Disease | 2000 | 414 |
| 7 | Epidemiology and outcomes of candidemia in 3648 patients: data from the Prospective Antifungal Therapy (PATH Alliance®) registry, 2004–2008 | Diagnostic Microbiology and Infectious Disease | 2012 | 345 |
| 8 | National Surveillance of Nosocomial Blood Stream Infection Due to Species of Candida Other than Candida albicans: Frequency of Occurrence and Antifungal Susceptibility in the SCOPE Program | Diagnostic Microbiology and Infectious Disease | 1998 | 331 |
| 9 | Occurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolates from the SENTRY Antimicrobial Surveillance Program (1997–2002) | Diagnostic Microbiology and Infectious Disease | 2004 | 329 |
| 10 | Contemporary causes of skin and soft tissue infections in North America, Latin America, and Europe: Report from the SENTRY Antimicrobial Surveillance Program (1998–2004) | Diagnostic Microbiology and Infectious Disease | 2007 | 328 |
| 11 | Clinical, molecular, and epidemiological characterization of the SARS-CoV-2 virus and the Coronavirus Disease 2019 (COVID-19), a comprehensive literature review | Diagnostic Microbiology and Infectious Disease | 2020 | 310 |
| 12 | National Surveillance of Nosocomial Blood Stream Infection Due to Candida albicans: Frequency of Occurrence and Antifungal Susceptibility in the SCOPE Program | Diagnostic Microbiology and Infectious Disease | 1998 | 295 |
| 13 | Carbapenem-resistant Enterobacteriaceae: a review of treatment and outcomes | Diagnostic Microbiology and Infectious Disease | 2013 | 291 |
| 14 | Surveillance of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States in 1996–1997 respiratory season | Diagnostic Microbiology and Infectious Disease | 1997 | 286 |
| 15 | The changing epidemiology of healthcare-associated candidemia over three decades | Diagnostic Microbiology and Infectious Disease | 2012 | 284 |
| 16 | Lysis—centrifugation blood cultures in the detection of tissue-proven invasive candidiasis disseminated versus single-organ infection | Diagnostic Microbiology and Infectious Disease | 1993 | 282 |
| 17 | Antimicrobial resistance and molecular epidemiology of vancomycin-resistant enterococci from North America and Europe: a report from the SENTRY antimicrobial surveillance program | Diagnostic Microbiology and Infectious Disease | 2007 | 282 |
| 18 | Comparison of prevalence of virulence factors for Klebsiella pneumoniae liver abscesses between isolates with capsular K1/K2 and non-K1/K2 serotypes | Diagnostic Microbiology and Infectious Disease | 2008 | 268 |
| 19 | In Vitro Activity of Two Echinocandin Derivatives, LY303366 and MK-0991 (L-743,792), Against Clinical Isolates of Aspergillus, Fusarium, Rhizopus, and Other Filamentous Fungi | Diagnostic Microbiology and Infectious Disease | 1998 | 254 |
| 20 | Comparison of tigecycline with imipenem/cilastatin for the treatment of hospital-acquired pneumonia | Diagnostic Microbiology and Infectious Disease | 2010 | 254 |
| 21 | Screening for amino acid substitutions in the Candida albicans Erg11 protein of azole-susceptible and azole-resistant clinical isolates: new substitutions and a review of the literature | Diagnostic Microbiology and Infectious Disease | 2010 | 240 |
| 22 | Antimicrobial resistance among Gram-negative bacilli isolated from Latin America: results from SENTRY Antimicrobial Surveillance Program (Latin America, 2008–2010) | Diagnostic Microbiology and Infectious Disease | 2012 | 228 |
| 23 | International surveillance of blood stream infections due to Candida species in the European SENTRY program: species distribution and antifungal susceptibility including the investigational triazole and echinocandin agents | Diagnostic Microbiology and Infectious Disease | 1999 | 227 |
| 24 | In vitro activities of voriconazole, posaconazole, and fluconazole against 4,169 clinical isolates of Candida spp. and Cryptococcus neoformans collected during 2001 and 2002 in the ARTEMIS global antifungal surveillance program | Diagnostic Microbiology and Infectious Disease | 2004 | 223 |
| 25 | Survey of blood stream infections attributable to gram-positive cocci: frequency of occurrence and antimicrobial susceptibility of isolates collected in 1997 in the United States, Canada, and Latin America from the SENTRY antimicrobial surveillance program | Diagnostic Microbiology and Infectious Disease | 1999 | 218 |
| 26 | Predominance of two newly described capsular polysaccharide types among clinical isolates of Staphylococcus aureus | Diagnostic Microbiology and Infectious Disease | 1984 | 214 |
| 27 | Polymicrobial bloodstream infections involving Candida species: analysis of patients and review of the literature | Diagnostic Microbiology and Infectious Disease | 2007 | 211 |
| 28 | Synergy assessed by checkerboard a critical analysis | Diagnostic Microbiology and Infectious Disease | 1993 | 208 |
| 29 | The PATH (Prospective Antifungal Therapy) Alliance® registry and invasive fungal infections: update 2012 | Diagnostic Microbiology and Infectious Disease | 2012 | 206 |
| 30 | Trends in species distribution and susceptibility to fluconazole among blood stream isolates of Candida species in the United States | Diagnostic Microbiology and Infectious Disease | 1999 | 199 |
| 31 | Candida parapsilosis Fungemia Associated with Implantable and Semi-Implantable Central Venous Catheters and the Hands of Healthcare Workers | Diagnostic Microbiology and Infectious Disease | 1998 | 190 |
| 32 | Epidemiologic typing of multiply drug-resistant Pseudomonas aeruginosa isolated from an outbreak in an intensive care unit | Diagnostic Microbiology and Infectious Disease | 1993 | 188 |
| 33 | Antimicrobial susceptibility of Gram-negative organisms isolated from patients hospitalized in intensive care units in United States and European hospitals (2009–2011) | Diagnostic Microbiology and Infectious Disease | 2014 | 187 |
| 34 | Rapid identification of pathogens from positive blood cultures by multiplex polymerase chain reaction using the FilmArray system | Diagnostic Microbiology and Infectious Disease | 2012 | 186 |
| 35 | Epidemiology and diagnosis of Shiga toxin-producing Escherichia coli infections | Diagnostic Microbiology and Infectious Disease | 1999 | 179 |
| 36 | The Shiga toxin genotype rather than the amount of Shiga toxin or the cytotoxicity of Shiga toxin in vitro correlates with the appearance of the hemolytic uremic syndrome | Diagnostic Microbiology and Infectious Disease | 2007 | 178 |
| 37 | Antimicrobial activity and spectrum of the new glycylcycline, GAR-936 tested against 1,203 recent clinical bacterial isolates | Diagnostic Microbiology and Infectious Disease | 2000 | 177 |
| 38 | Epidemiology and frequency of resistance among pathogens causing urinary tract infections in 1,510 hospitalized patients: A report from the SENTRY Antimicrobial Surveillance Program (North America) | Diagnostic Microbiology and Infectious Disease | 2001 | 177 |
| 39 | Clinical and economic impact of methicillin resistance in patients with Staphylococcus aureus bacteremia | Diagnostic Microbiology and Infectious Disease | 2005 | 177 |
| 40 | Drug intolerance to high-dose clarithromycin among elderly patients | Diagnostic Microbiology and Infectious Disease | 1993 | 171 |
| 41 | A nationwide, multicenter, case-control study comparing risk factors, treatment, and outcome for vancomycin-resistant and -susceptible enterococcal bacteremia☆ | Diagnostic Microbiology and Infectious Disease | 2000 | 171 |
| 42 | Development of a multiplex real-time quantitative PCR assay to detect Chlamydia pneumoniae, Legionella pneumophila and Mycoplasma pneumoniae in respiratory tract secretions | Diagnostic Microbiology and Infectious Disease | 2003 | 169 |
| 43 | Tigecycline: an update | Diagnostic Microbiology and Infectious Disease | 2013 | 167 |
| 44 | Detecting Blastocystis using parasitologic and DNA-based methods: a comparative study | Diagnostic Microbiology and Infectious Disease | 2007 | 165 |
| 45 | The central nervous system and infection by Candida species | Diagnostic Microbiology and Infectious Disease | 2000 | 164 |
| 46 | Antimicrobial stewardship: concepts and strategies in the 21st century | Diagnostic Microbiology and Infectious Disease | 2008 | 163 |
| 47 | Human infections due to Staphylococcus pseudintermedius, an emerging zoonosis of canine origin: report of 24 cases | Diagnostic Microbiology and Infectious Disease | 2016 | 163 |
| 48 | Summary trends for the Meropenem Yearly Susceptibility Test Information Collection Program: a 10-year experience in the United States (1999–2008) | Diagnostic Microbiology and Infectious Disease | 2009 | 161 |
| 49 | Serological diagnosis of Toxoplasma gondii infection | Diagnostic Microbiology and Infectious Disease | 2016 | 161 |
| 50 | High rate of non-albicans candidemia in Brazilian tertiary care hospitals | Diagnostic Microbiology and Infectious Disease | 1999 | 158 |
